{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:31:39Z","timestamp":1773797499519,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Research Fund of Zhoukou Hospital of Traditional Chinese Medicine","award":["zkszyy2024001"],"award-info":[{"award-number":["zkszyy2024001"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2020M682334"],"award-info":[{"award-number":["2020M682334"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Henan Postdoctoral Foundation","award":["202003002"],"award-info":[{"award-number":["202003002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-024-01314-4","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T07:20:16Z","timestamp":1725952816000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A cancer-associated fibroblasts related risk score (CAFscore) helps to guide prognosis and personal treatment for Glioblastoma"],"prefix":"10.1007","volume":"15","author":[{"given":"Lili","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinjian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoyin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weidong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weifeng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,10]]},"reference":[{"key":"1314_CR1","first-page":"357","volume":"9","author":"ND Arvold","year":"2014","unstructured":"Arvold ND, Reardon DA. Treatment options and outcomes for glioblastoma in the elderly patient. Clin Interv Aging. 2014;9:357\u201367.","journal-title":"Clin Interv Aging"},{"issue":"10","key":"1314_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987\u201396.","journal-title":"N Engl J Med"},{"issue":"17","key":"1314_CR3","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1001\/jama.2013.280319","volume":"310","author":"A Omuro","year":"2013","unstructured":"Omuro A, DeAngelis LM. Glioblastoma and other malignant gliomas: a clinical review. JAMA. 2013;310(17):1842\u201350.","journal-title":"JAMA"},{"issue":"11","key":"1314_CR4","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1001\/jamaoncol.2016.1373","volume":"2","author":"TJ Brown","year":"2016","unstructured":"Brown TJ, Brennan MC, Li M, Church EW, Brandmeir NJ, Rakszawski KL, Patel AS, Rizk EB, Suki D, Sawaya R, et al. Association of the extent of resection with survival in glioblastoma: a systematic review and meta-analysis. JAMA Oncol. 2016;2(11):1460\u20139.","journal-title":"JAMA Oncol"},{"key":"1314_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2019.101896","volume":"80","author":"E Le Rhun","year":"2019","unstructured":"Le Rhun E, Preusser M, Roth P, Reardon DA, van den Bent M, Wen P, Reifenberger G, Weller M. Molecular targeted therapy of glioblastoma. Cancer Treat Rev. 2019;80: 101896.","journal-title":"Cancer Treat Rev"},{"key":"1314_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.944452","volume":"13","author":"AB Mahmoud","year":"2022","unstructured":"Mahmoud AB, Ajina R, Aref S, Darwish M, Alsayb M, Taher M, AlSharif SA, Hashem AM, Alkayyal AA. Advances in immunotherapy for glioblastoma multiforme. Front Immunol. 2022;13: 944452.","journal-title":"Front Immunol"},{"issue":"7","key":"1314_CR7","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/s43018-022-00411-z","volume":"3","author":"D Lavie","year":"2022","unstructured":"Lavie D, Ben-Shmuel A, Erez N, Scherz-Shouval R. Cancer-associated fibroblasts in the single-cell era. Nat Cancer. 2022;3(7):793\u2013807.","journal-title":"Nat Cancer"},{"issue":"1","key":"1314_CR8","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12943-023-01876-x","volume":"22","author":"C Ma","year":"2023","unstructured":"Ma C, Yang C, Peng A, Sun T, Ji X, Mi J, Wei L, Shen S, Feng Q. Pan-cancer spatially resolved single-cell analysis reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment. Mol Cancer. 2023;22(1):170.","journal-title":"Mol Cancer"},{"issue":"1","key":"1314_CR9","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","volume":"20","author":"X Mao","year":"2021","unstructured":"Mao X, Xu J, Wang W, Liang C, Hua J, Liu J, Zhang B, Meng Q, Yu X, Shi S. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer. 2021;20(1):131.","journal-title":"Mol Cancer"},{"issue":"4","key":"1314_CR10","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ccell.2024.02.002","volume":"42","author":"H Zheng","year":"2024","unstructured":"Zheng H, An M, Luo Y, Diao X, Zhong W, Pang M, Lin Y, Chen J, Li Y, Kong Y, et al. PDGFRalpha(+)ITGA11(+) fibroblasts foster early-stage cancer lymphovascular invasion and lymphatic metastasis via ITGA11-SELE interplay. Cancer Cell. 2024;42(4):682\u2013700.","journal-title":"Cancer Cell"},{"issue":"4","key":"1314_CR11","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1158\/1078-0432.CCR-23-0493","volume":"30","author":"PM Galbo Jr","year":"2024","unstructured":"Galbo PM Jr, Madsen AT, Liu Y, Peng M, Wei Y, Ciesielski MJ, Fenstermaker RA, Graff S, Montagna C, Segall JE, et al. Functional contribution and clinical implication of cancer-associated fibroblasts in glioblastoma. Clin Cancer Res. 2024;30(4):865\u201376.","journal-title":"Clin Cancer Res"},{"key":"1314_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1172\/JCI147087","volume":"133","author":"S Jain","year":"2023","unstructured":"Jain S, Rick JW, Joshi RS, Beniwal A, Spatz J, Gill S, Chang AC, Choudhary N, Nguyen AT, Sudhir S, et al. Single-cell RNA sequencing and spatial transcriptomics reveal cancer-associated fibroblasts in glioblastoma with protumoral effects. J Clin Invest. 2023;133:5.","journal-title":"J Clin Invest"},{"issue":"1","key":"1314_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1152\/physrev.00048.2019","volume":"101","author":"G Biffi","year":"2021","unstructured":"Biffi G, Tuveson DA. Diversity and biology of cancer-associated fibroblasts. Physiol Rev. 2021;101(1):147\u201376.","journal-title":"Physiol Rev"},{"key":"1314_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.914612","volume":"13","author":"Z Zhu","year":"2022","unstructured":"Zhu Z, Li G, Li Z, Wu Y, Yang Y, Wang M, Zhang H, Qu H, Song Z, He Y. Core immune cell infiltration signatures identify molecular subtypes and promote precise checkpoint immunotherapy in cutaneous melanoma. Front Immunol. 2022;13: 914612.","journal-title":"Front Immunol"},{"issue":"9","key":"1314_CR15","doi-asserted-by":"publisher","first-page":"3442","DOI":"10.18632\/aging.204680","volume":"15","author":"X Li","year":"2023","unstructured":"Li X, Kang J, Yue J, Xu D, Liao C, Zhang H, Zhao J, Liu Q, Jiao J, Wang L, et al. Identification and validation of immunogenic cell death-related score in uveal melanoma to improve prediction of prognosis and response to immunotherapy. Aging (Albany NY). 2023;15(9):3442\u201364.","journal-title":"Aging (Albany NY)"},{"key":"1314_CR16","unstructured":"Jun Z: GseaVis: An Implement R Package to Visualize GSEA Results. 2022."},{"issue":"D1","key":"1314_CR17","doi-asserted-by":"publisher","first-page":"D900","DOI":"10.1093\/nar\/gky939","volume":"47","author":"H Yuan","year":"2019","unstructured":"Yuan H, Yan M, Zhang G, Liu W, Deng C, Liao G, Xu L, Luo T, Yan H, Long Z, et al. CancerSEA: a cancer single-cell state atlas. Nucleic Acids Res. 2019;47(D1):D900\u20138.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"1314_CR18","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.1096\/fj.201903188R","volume":"34","author":"VS LeBleu","year":"2020","unstructured":"LeBleu VS, Neilson EG. Origin and functional heterogeneity of fibroblasts. FASEB J. 2020;34(3):3519\u201336.","journal-title":"FASEB J"},{"key":"1314_CR19","first-page":"6","volume":"8","author":"Z Li","year":"2019","unstructured":"Li Z, Zhang J, Zhou J, Lu L, Wang H, Zhang G, Wan G, Cai S, Du J. Nodal facilitates differentiation of fibroblasts to cancer-associated fibroblasts that support tumor growth in melanoma and colorectal cancer. Cells. 2019;8:6.","journal-title":"Cells"},{"key":"1314_CR20","first-page":"21","volume":"21","author":"K Kim","year":"2020","unstructured":"Kim K, Sohn YJ, Lee R, Yoo HJ, Kang JY, Choi N, Na D, Yeon JH. Cancer-associated fibroblasts differentiated by exosomes isolated from cancer cells promote cancer cell invasion. Int J Mol Sci. 2020;21:21.","journal-title":"Int J Mol Sci"},{"issue":"38","key":"1314_CR21","doi-asserted-by":"publisher","first-page":"E5618","DOI":"10.1073\/pnas.1608384113","volume":"113","author":"K Hosaka","year":"2016","unstructured":"Hosaka K, Yang Y, Seki T, Fischer C, Dubey O, Fredlund E, Hartman J, Religa P, Morikawa H, Ishii Y, et al. Pericyte-fibroblast transition promotes tumor growth and metastasis. Proc Natl Acad Sci U S A. 2016;113(38):E5618-5627.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"23","key":"1314_CR22","doi-asserted-by":"publisher","first-page":"8492","DOI":"10.1158\/0008-5472.CAN-04-1708","volume":"64","author":"NC Direkze","year":"2004","unstructured":"Direkze NC, Hodivala-Dilke K, Jeffery R, Hunt T, Poulsom R, Oukrif D, Alison MR, Wright NA. Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res. 2004;64(23):8492\u20135.","journal-title":"Cancer Res"},{"issue":"17","key":"1314_CR23","doi-asserted-by":"publisher","first-page":"8322","DOI":"10.7150\/thno.62378","volume":"11","author":"Z Li","year":"2021","unstructured":"Li Z, Sun C, Qin Z. Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming. Theranostics. 2021;11(17):8322\u201336.","journal-title":"Theranostics"},{"issue":"2","key":"1314_CR24","doi-asserted-by":"publisher","first-page":"620","DOI":"10.7150\/thno.60540","volume":"12","author":"X Li","year":"2022","unstructured":"Li X, Sun Z, Peng G, Xiao Y, Guo J, Wu B, Li X, Zhou W, Li J, Li Z, et al. Single-cell RNA sequencing reveals a pro-invasive cancer-associated fibroblast subgroup associated with poor clinical outcomes in patients with gastric cancer. Theranostics. 2022;12(2):620\u201338.","journal-title":"Theranostics"},{"issue":"12","key":"1314_CR25","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/s41423-022-00930-w","volume":"19","author":"HJ Kim","year":"2022","unstructured":"Kim HJ, Yang K, Kim K, Lee YJ, Lee S, Ahn SY, Ahn YH, Kang JL. Reprogramming of cancer-associated fibroblasts by apoptotic cancer cells inhibits lung metastasis via Notch1-WISP-1 signaling. Cell Mol Immunol. 2022;19(12):1373\u201391.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"1314_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28285","volume":"95","author":"L Chen","year":"2023","unstructured":"Chen L, Zhao X, Liu Y, Wu M, Li S, Xu C, Shi Y. Comprehensive analysis of HHV-6 and HHV-7-related gene signature in prognosis and response to temozolomide of glioma. J Med Virol. 2023;95(1): e28285.","journal-title":"J Med Virol"},{"key":"1314_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/cancers13071730","volume":"13","author":"R Tian","year":"2021","unstructured":"Tian R, Li Y, Liu Q, Shu M. Identification and validation of an immune-associated RNA-binding proteins signature to predict clinical outcomes and therapeutic responses in glioma patients. Cancers. 2021;13:7.","journal-title":"Cancers"},{"issue":"4","key":"1314_CR28","doi-asserted-by":"publisher","first-page":"5071","DOI":"10.1002\/cam4.5247","volume":"12","author":"J Chen","year":"2023","unstructured":"Chen J, Chen S, Li B, Zhou S, Lin H. A pyroptosis-related signature predicts prognosis and indicates immune microenvironment infiltration in glioma. Cancer Med. 2023;12(4):5071\u201387.","journal-title":"Cancer Med"},{"key":"1314_CR29","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/medicina59020414","volume":"59","author":"D Pan","year":"2023","unstructured":"Pan D, Fang X, Li J. Identification of a novel gene signature based on kinesin family members to predict prognosis in glioma. Medicina. 2023;59:2.","journal-title":"Medicina"},{"key":"1314_CR30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/medicina58101327","volume":"58","author":"S Wu","year":"2022","unstructured":"Wu S, Xu J, Li G, Jin X. Integrating radiosensitivity gene signature improves glioma outcome and radiotherapy response prediction. Medicina. 2022;58:10.","journal-title":"Medicina"},{"issue":"2","key":"1314_CR31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/COC.0000000000000780","volume":"44","author":"H Elinzano","year":"2021","unstructured":"Elinzano H, Toms S, Robison J, Mohler A, Carcieri A, Cielo D, Donnelly J, Disano D, Vatketich J, Baekey J, et al. Nanoliposomal irinotecan and metronomic temozolomide for patients with recurrent glioblastoma: BrUOG329, a phase I brown university oncology research group trial. Am J Clin Oncol. 2021;44(2):49\u201352.","journal-title":"Am J Clin Oncol"},{"issue":"32","key":"1314_CR32","doi-asserted-by":"publisher","first-page":"4945","DOI":"10.1200\/JCO.22.02772","volume":"41","author":"HS Friedman","year":"2023","unstructured":"Friedman HS, Prados MD, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WKA, Paleologos N, Nicholas MK, Jensen R, et al. Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol. 2023;41(32):4945\u201352.","journal-title":"J Clin Oncol"},{"issue":"7","key":"1314_CR33","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1634\/theoncologist.2015-0135","volume":"20","author":"KB Peters","year":"2015","unstructured":"Peters KB, Lou E, Desjardins A, Reardon DA, Lipp ES, Miller E, Herndon JE 2nd, McSherry F, Friedman HS, Vredenburgh JJ. Phase II trial of upfront bevacizumab, irinotecan, and temozolomide for unresectable glioblastoma. Oncologist. 2015;20(7):727\u20138.","journal-title":"Oncologist"},{"issue":"1","key":"1314_CR34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00018-024-05135-0","volume":"81","author":"A Carreras Mascaro","year":"2024","unstructured":"Carreras Mascaro A, Grochowska MM, Boumeester V, Dits NFJ, Bilgi\u04ab EN, Breedveld GJ, Vergouw L, de Jong FJ, van Royen ME, Bonifati V, et al. LRP10 and alpha-synuclein transmission in Lewy body diseases. Cell Mol Life Sci. 2024;81(1):75.","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"1314_CR35","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S1474-4422(18)30179-0","volume":"17","author":"M Quadri","year":"2018","unstructured":"Quadri M, Mandemakers W, Grochowska MM, Masius R, Geut H, Fabrizio E, Breedveld GJ, Kuipers D, Minneboo M, Vergouw LJM, et al. LRP10 genetic variants in familial Parkinson\u2019s disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study. Lancet Neurol. 2018;17(7):597\u2013608.","journal-title":"Lancet Neurol"},{"key":"1314_CR36","first-page":"4483","volume":"9","author":"J Russell","year":"2024","unstructured":"Russell J, Chen L, Liu A, Wang J, Ghosh S, Zhong X, Shi H, Beutler B, Nair-Gill E. Lrp10 suppresses IL7R limiting CD8 T cell homeostatic expansion and anti-tumor immunity. EMBO Rep. 2024;9:4483.","journal-title":"EMBO Rep"},{"issue":"16","key":"1314_CR37","doi-asserted-by":"publisher","first-page":"6020","DOI":"10.1002\/cam4.3281","volume":"9","author":"Y Li","year":"2020","unstructured":"Li Y, Shen Y, Zhu Z, Wen H, Feng C. Comprehensive analysis of copy number variance and sensitivity to common targeted therapy in clear cell renal cell carcinoma: In silico analysis with in vitro validation. Cancer Med. 2020;9(16):6020\u20139.","journal-title":"Cancer Med"},{"key":"1314_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112262","volume":"144","author":"L Dai","year":"2021","unstructured":"Dai L, Li Z, Tao Y, Liang W, Hu W, Zhou S, Fu X, Wang X. Emerging roles of suppressor of cytokine signaling 3 in human cancers. Biomed Pharmacother. 2021;144: 112262.","journal-title":"Biomed Pharmacother"},{"issue":"11\u201312","key":"1314_CR39","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1089\/hum.2022.185","volume":"34","author":"X Yang","year":"2023","unstructured":"Yang X, Tian M, Lin Y, Li L, Sun X, Zhang Z, Kang M, Lin J. Characterization of the roles of suppressor of cytokine signaling-3 in esophageal carcinoma. Hum Gene Ther. 2023;34(11\u201312):495\u2013517.","journal-title":"Hum Gene Ther"},{"key":"1314_CR40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1101\/cshperspect.a028571","volume":"10","author":"A Yoshimura","year":"2018","unstructured":"Yoshimura A, Ito M, Chikuma S, Akanuma T, Nakatsukasa H. Negative regulation of cytokine signaling in immunity. Cold Spring Harb Perspect Biol. 2018;10:7.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"1314_CR41","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12943-019-1063-6","volume":"18","author":"M Xu","year":"2019","unstructured":"Xu M, Xu X, Pan B, Chen X, Lin K, Zeng K, Liu X, Xu T, Sun L, Qin J, et al. LncRNA SATB2-AS1 inhibits tumor metastasis and affects the tumor immune cell microenvironment in colorectal cancer by regulating SATB2. Mol Cancer. 2019;18(1):135.","journal-title":"Mol Cancer"},{"issue":"11","key":"1314_CR42","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1002\/jcp.24067","volume":"227","author":"DM Salerno","year":"2012","unstructured":"Salerno DM, Tront JS, Hoffman B, Liebermann DA. Gadd45a and Gadd45b modulate innate immune functions of granulocytes and macrophages by differential regulation of p38 and JNK signaling. J Cell Physiol. 2012;227(11):3613\u201320.","journal-title":"J Cell Physiol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-024-01314-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-024-01314-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-024-01314-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T19:08:11Z","timestamp":1725995291000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-024-01314-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,10]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1314"],"URL":"https:\/\/doi.org\/10.1007\/s12672-024-01314-4","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,10]]},"assertion":[{"value":"7 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"420"}}